133 related articles for article (PubMed ID: 2145669)
1. Activation of human T cells in vivo following treatment of transplant recipients with OKT3.
Ellenhorn JD; Woodle ES; Ghobreal I; Thistlethwaite JR; Bluestone JA
Transplantation; 1990 Oct; 50(4):608-12. PubMed ID: 2145669
[TBL] [Abstract][Full Text] [Related]
2. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
Panzer S; Geller RL; Bach FH
Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
[TBL] [Abstract][Full Text] [Related]
3. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
Woodle ES; Thistlethwaite JR; Ghobrial IA; Jolliffe LK; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):354-60. PubMed ID: 1908148
[TBL] [Abstract][Full Text] [Related]
4. Polymorphonuclear neutrophils enhance anti-CD3-induced T cell activation: the role of polymorphonuclear FC-receptors.
Bentin J; Koutsoukos M; Pierart M; Appelboom T; Ceuppens JL
Cell Immunol; 1991 Feb; 132(2):339-49. PubMed ID: 1824828
[TBL] [Abstract][Full Text] [Related]
5. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to common epitopes of the human alpha/beta T-cell receptor preferentially activate CD45RA+ T-cells.
Schwinzer R; Schlitt HJ; Wonigeit K
Cell Immunol; 1992 Mar; 140(1):31-41. PubMed ID: 1531453
[TBL] [Abstract][Full Text] [Related]
8. T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody.
Gebel HM; Lebeck LK; Jensik SC; Webster K; Bray RA
Hum Immunol; 1989 Oct; 26(2):123-9. PubMed ID: 2479623
[TBL] [Abstract][Full Text] [Related]
9. Regulation of expression of interleukin 2 receptors upon triggering of the TCR-CD3 complex on human T lymphocytes.
Kabouridis PS; Tsoukas CD
Immunol Invest; 1990 Aug; 19(4):385-401. PubMed ID: 2145219
[TBL] [Abstract][Full Text] [Related]
10. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
11. The role of OKT3 in clinical transplantation.
Norman DJ; Leone MR
Pediatr Nephrol; 1991 Jan; 5(1):130-6. PubMed ID: 1827342
[TBL] [Abstract][Full Text] [Related]
12. The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation.
Frenken LA; Koene RA; Tax WJ
Transplantation; 1991 Apr; 51(4):881-7. PubMed ID: 1826571
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent activation of murine T cells following in vivo administration of anti-murine CD3.
Ellenhorn JD; Hirsch R; Hartley JP; Bluestone JA
Transplant Proc; 1989 Feb; 21(1 Pt 1):1013-4. PubMed ID: 2523110
[No Abstract] [Full Text] [Related]
14. OKT3 induction via idiotypic networks of mirror-image immunosuppressive antiimmunoglobulins in renal transplant recipients.
Carreno M; Yang WC; Esquenazi V; Fuller L; Burke G; Milgrom M; Roth D; Ranjan D; Miller J
Transplantation; 1990 Feb; 49(2):408-15. PubMed ID: 1689519
[TBL] [Abstract][Full Text] [Related]
15. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
Rothman BL; Blue ML; Kelley KA; Wunderlich D; Mierz DV; Aune TM
J Immunol; 1991 Oct; 147(8):2493-9. PubMed ID: 1833455
[TBL] [Abstract][Full Text] [Related]
16. The cascading, interrelated roles of interleukin-1, interleukin-2, and interleukin-6 in murine anti-CD3-driven T cell proliferation.
Pankewycz OG; Yui M; Kelley VE; Strom TB
Clin Immunol Immunopathol; 1990 Apr; 55(1):67-85. PubMed ID: 2137741
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of anti-CD3 monoclonal antibodies. Mediation of cytolysis by inter-T cell bridging.
Wong JT; Eylath AA; Ghobrial I; Colvin RB
Transplantation; 1990 Oct; 50(4):683-9. PubMed ID: 2145670
[TBL] [Abstract][Full Text] [Related]
18. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody OKT3-induced T cell proliferation: differential role of HLA class II determinants expressed by T cells and monocytes.
Manzo C; Ruggiero G; del Vecchio L; Racioppi L; Pirozzi G; Temponi M; Ferrone S; Fontana S; Zappacosta S
Cell Immunol; 1990 Jan; 125(1):79-91. PubMed ID: 1688405
[TBL] [Abstract][Full Text] [Related]
20. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
